MedPath

安徽博诺美科生物医药有限公司

Ownership
-
Established
2019-04-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Bisoprolol Fumarate and Amlodipine Besilate Tablets

Product Name
比索洛尔氨氯地平片
Approval Number
国药准字H20249788
Approval Date
Dec 25, 2024
NMPA

Rivaroxaban Tablets

Product Name
利伐沙班片
Approval Number
国药准字H20244528
Approval Date
Jul 30, 2024
NMPA

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸莫西沙星氯化钠注射液
Approval Number
国药准字H20234176
Approval Date
Sep 19, 2023
NMPA

Carbazochrome Sodium Sulfonate Injection

Product Name
卡络磺钠注射液
Approval Number
国药准字H20060805
Approval Date
Sep 23, 2021
NMPA

Diphenhydramine Hydrochloride Tablets

Product Name
盐酸苯海拉明片
Approval Number
国药准字H34020955
Approval Date
Apr 22, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.